Compounds > 3-aminobenzamide

3-aminobenzamide and melphalan

3-aminobenzamide has been researched along with melphalan in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Dozi-Vassiliades, J; Hatzitheodoridou, P; Koliouskas, DE; Kourakis, A; Mourelatos, D1
Brown, DM; Brown, JM; Hirst, DG; Horsman, MR2
Stephens, MA; Stratford, IJ; Walling, JM1
Hasmann, M; Nüssler, V; Pelka-Fleischer, R; Pogrebniak, A; Schemainda, I1

Other Studies

6 other study(ies) available for 3-aminobenzamide and melphalan

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Enhancement of cytogenetic damage by inhibitors of poly(ADP-ribose)polymerase in human lymphocytes exposed to antineoplastics in vivo and in vitro.
    Teratogenesis, carcinogenesis, and mutagenesis, 1986, Volume: 6, Issue:6

    Topics: Benzamides; Bromodeoxyuridine; Cell Division; Colchicine; Drug Synergism; Humans; Kinetics; Lymphocytes; Melphalan; Mutagens; Poly(ADP-ribose) Polymerase Inhibitors; Sister Chromatid Exchange; Thiotepa

1986
Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferase.
    British journal of cancer, 1986, Volume: 53, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Body Temperature; Cell Survival; Dose-Response Relationship, Drug; Female; Leukocyte Count; Melphalan; Mice; Mice, Inbred C3H; Niacinamide; Nucleotidyltransferases; Poly(ADP-ribose) Polymerases; Sarcoma, Experimental; Time Factors

1986
Enhancement of melphalan cytotoxicity in vivo and in vitro by inhibitors of poly (ADP-ribose) polymerase.
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:9

    Topics: Animals; Benzamides; Caffeine; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Melphalan; Mice; Mice, Inbred C3H; NAD+ Nucleosidase; Neoplasm Transplantation; Neoplasms, Experimental; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Time Factors

1984
Chemopotentiation by CB 1954: the importance of postincubations and the possible involvement of poly(ADP-ribosylation).
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:9

    Topics: Animals; Aziridines; Azirines; Benzamides; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Drug Synergism; Melphalan; Methylnitronitrosoguanidine; Poly(ADP-ribose) Polymerase Inhibitors; Radiation-Sensitizing Agents

1984
Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    European journal of medical research, 2003, Oct-22, Volume: 8, Issue:10

    Topics: 1-Naphthylamine; Adenosine Triphosphate; Alkylating Agents; Apoptosis; Benzamides; Cell Death; Cell Line, Tumor; Cell Size; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia; Melphalan; Methylnitronitrosoguanidine; NAD; Naphthalimides; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolones

2003